Founded in March of 2019, Medical Research Collaborative, LLC represents a collaborative effort, bringing together expertise from various fields of scientific endeavor, as well as in matters of foreign and domestic (US) patent law and regulatory science, directly applicable to a systematic, thorough analysis of companies in the healthcare sector, with key focus on pharmaceutical and biotechnology industry players. Such a diverse blend of expertise concentrated on one company yields an unmatched level of analysis, which is then further refined by a high degree of financial modeling, to assist in the ultimate decision to buy, hold, avoid, or sell short the stock of companies within our purview, as well as inform on the merits/drawbacks of targeted partnerships and M&A.
Our commitment is to provide substantial, par excellence multi-disciplinary research reports on individual healthcare companies, and as part of this commitment, we avoid actively trading the securities of individual going concerns to help ensure our analysis is tinged with as little bias as possible. We further expose our analysis to independent experts not associated with Medical Research Collaborative, LLC (and without any perceived conflicts of interest) as part of our peer-review process. The final result is then published by us and offered for sale to interested parties.
We may also be contracted to conduct customized analyses to meet your firm’s unique needs.